Courier Capital LLC Grows Stock Holdings in Danaher Co. (NYSE:DHR)

Courier Capital LLC boosted its holdings in shares of Danaher Co. (NYSE:DHR) by 77.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,733 shares of the conglomerate’s stock after purchasing an additional 1,627 shares during the quarter. Courier Capital LLC’s holdings in Danaher were worth $765,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of DHR. Norges Bank purchased a new stake in Danaher during the fourth quarter valued at $2,130,740,000. GAMMA Investing LLC raised its stake in shares of Danaher by 24,958.2% in the first quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate’s stock valued at $383,524,000 after acquiring an additional 1,863,381 shares during the period. Raymond James Financial Inc. purchased a new stake in shares of Danaher in the fourth quarter valued at $391,172,000. Two Sigma Advisers LP raised its stake in shares of Danaher by 4,248.8% in the fourth quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate’s stock valued at $376,347,000 after acquiring an additional 1,601,800 shares during the period. Finally, Capital World Investors raised its stake in shares of Danaher by 32.7% in the fourth quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate’s stock valued at $1,460,215,000 after acquiring an additional 1,566,658 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

DHR has been the topic of several recent analyst reports. Leerink Partners increased their target price on shares of Danaher from $225.00 to $230.00 and gave the company an “outperform” rating in a research note on Wednesday, April 23rd. Barclays raised their price target on shares of Danaher from $205.00 to $215.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 22nd. Robert W. Baird reduced their price target on shares of Danaher from $231.00 to $225.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Citigroup restated a “buy” rating on shares of Danaher in a report on Monday, April 7th. Finally, Wolfe Research lowered their price target on shares of Danaher from $275.00 to $220.00 and set an “outperform” rating on the stock in a report on Monday, April 7th. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $248.17.

Danaher Stock Performance

DHR opened at $199.26 on Tuesday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The firm has a fifty day moving average price of $191.22 and a 200 day moving average price of $211.78. Danaher Co. has a 1 year low of $171.00 and a 1 year high of $281.70. The stock has a market cap of $142.60 billion, a P/E ratio of 37.74, a P/E/G ratio of 2.66 and a beta of 0.77.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The firm had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.58 billion. Equities research analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.64%. Danaher’s dividend payout ratio is currently 24.85%.

Insider Activity at Danaher

In related news, Chairman Steven M. Rales sold 1,250,000 shares of the business’s stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the sale, the chairman now owns 3,105,808 shares of the company’s stock, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of the business’s stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the sale, the executive vice president now directly owns 15,179 shares of the company’s stock, valued at approximately $3,005,442. The trade was a 51.01% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.